e.g. mhealth
Search Results (1 to 2 of 2 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 1 JMIR Cancer
- 1 JMIR Research Protocols
- 0 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 JMIR Formative Research
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Osteosarcoma is a primary malignancy of the bone, affecting 3.4 million individuals globally each year, and is the third most common cancer in the adolescent population [1]. The current treatment for osteosarcoma consists of complete surgical resection coupled with neoadjuvant and adjuvant chemotherapy. Though the introduction of adjuvant chemotherapy in the 1970s has greatly improved survival [2], the diagnosis of osteosarcoma is a significant, life-altering event for patients.
JMIR Cancer 2022;8(1):e25005
Download Citation: END BibTex RIS
Treatment outcomes for patients diagnosed during adolescence and young adulthood with the most common bone sarcomas, osteosarcoma (OS), and Ewing sarcoma have improved over the past 30 years with the evidence-based introduction of intensive chemotherapy, wide-margin surgery, and, for some, radiation treatment [1-5]. The 5-year survival rate has improved especially for patients aged younger than 25 years [6].
JMIR Res Protoc 2019;8(9):e14406
Download Citation: END BibTex RIS